The European Centre for Disease Prevention and Control (ECDC) reports that chronic diseases account for over 80% of healthcare burden in Europe, while multiple EU countries have expanded reimbursement frameworks, improving access to innovative therapies like GLP-1 receptor agonists
LEGAL BATTLE: Eli Lilly targets Houston-based Empower Pharmacy over copycat diabetes, weight loss drugs Compounders can make drugs that arent in shortage, as long as the drugs have medically necessary changes, as prescribed by a physician
Gastrointestinal Patients People suffering from gastrointestinal issues, including ulcers and IBD, can benefit from the healing properties of this peptide
Together, these actions may contribute to better bowel regularity and less straining, especially for those with chronic or idiopathic constipation
I will update this Log in a couple of weeks to update my condition